Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
复制标题
DOI:
10.1073/pnas.2103272118
复制
发表时间:
2021-08-03
影响因子:
11.1
通讯作者:
Raftery AE
中科院分区:
文献类型:
--
作者:
Irons NJ;Raftery AE
The novel coronavirus SARS-CoV-2 has infected over 33 million people in the United States. Nationwide, over 600,000 have died in the COVID-19 pandemic, which has necessitated shutdowns of schools and sectors of the economy. The extent of the virus’ spread remains uncertain due to biases in test data. We combine multiple data sources to estimate the true number of infections in all US states. These data include representative random testing surveys from Indiana and Ohio, which provide potentially unbiased prevalence estimates. We find that approximately 60% of infections have gone unreported. Even so, only about 20% of the United States had been infected as of early March 2021, suggesting that the country was far from herd immunity at that point. There are multiple sources of data giving information about the number of SARS-CoV-2 infections in the population, but all have major drawbacks, including biases and delayed reporting. For example, the number of confirmed cases largely underestimates the number of infections, and deaths lag infections substantially, while test positivity rates tend to greatly overestimate prevalence. Representative random prevalence surveys, the only putatively unbiased source, are sparse in time and space, and the results can come with big delays. Reliable estimates of population prevalence are necessary for understanding the spread of the virus and the effectiveness of mitigation strategies. We develop a simple Bayesian framework to estimate viral prevalence by combining several of the main available data sources. It is based on a discrete-time Susceptible–Infected–Removed (SIR) model with time-varying reproductive parameter. Our model includes likelihood components that incorporate data on deaths due to the virus, confirmed cases, and the number of tests administered on each day. We anchor our inference with data from random-sample testing surveys in Indiana and Ohio. We use the results from these two states to calibrate the model on positive test counts and proceed to estimate the infection fatality rate and the number of new infections on each day in each state in the United States. We estimate the extent to which reported COVID cases have underestimated true infection counts, which was large, especially in the first months of the pandemic. We explore the implications of our results for progress toward herd immunity.
登录
查看更多内容
DOI:
10.1016/j.amjmed.2020.09.024
发表时间:
2021-04
期刊:
The American journal of medicine
影响因子:
--
作者:
Mahajan S;Srinivasan R;Redlich CA;Huston SK;Anastasio KM;Cashman L;Massey DS;Dugan A;Witters D;Marlar J;Li SX;Lin Z;Hodge D;Chattopadhyay M;Adams MD;Lee C;Rao LV;Stewart C;Kuppusamy K;Ko AI;Krumholz HM
通讯作者:
Krumholz HM
影响因子:
11.1
作者:
Lu, Jing;Peng, Jinju;Ke, Changwen
通讯作者:
Ke, Changwen
影响因子:
11.8
作者:
Bullard, Jared;Dust, Kerry;Poliquin, Guillaume
通讯作者:
Poliquin, Guillaume
DOI:
10.1016/j.ijid.2020.09.1464
发表时间:
2020-12
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Meyerowitz-Katz G;Merone L
通讯作者:
Merone L
影响因子:
82.9
作者:
He, Xi;Lau, Eric H. Y.;Leung, Gabriel M.
通讯作者:
Leung, Gabriel M.